Celltrion HealthCare Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion HealthCare Co Ltd with three other
companies in this sector in South Korea:
Medy Tox Inc
sales of 205.44 billion Korean Won [US$169.49 million]
of which 95%
was Finished Goods),
Samsung Biologics Co Ltd
(535.81 billion Korean Won [US$442.04 million]
of which 99%
was Antibody Drugs), and
(982.07 billion Korean Won [US$810.21 million]
of which 88%
was Bio Business Division).